A new Periodic Transaction Report filed under the STOCK Act shows that the spouse of Rep. Kelly Louise Morrison (D), a member of the U.S. House of Representatives, sold shares of Solstice Advanced Materials Inc. (ticker: SOLS) on August 11, 2026. The transaction, disclosed as a sale valued between $1,001 and $15,000, was made through an account identified as Trust 2. Our internal classification tags this filing as a congress sale.
Periodic Transaction Reports are required within 45 days of a covered transaction by the member, spouse, or dependent child, and they disclose only a dollar range rather than an exact sale amount. That means the precise size of this SOLS transaction is not publicly known beyond the $1,001-$15,000 bracket reported to the Clerk of the House.
A Cross-Signal Worth Watching
What makes this filing notable is its timing relative to activity inside the company itself. Company insider Mawson Simon also sold SOLS stock, on August 1, 2026, in a transaction reported at $0 in value, according to separate insider trading disclosures. That sale occurred just ten days before the Morrison household transaction and falls within the same 30-day window our tracking system flags as a potential pattern worth surfacing to readers.
Seeing both a congressional trading disclosure and a company insider disclosure for the same ticker in a short span does not, on its own, establish any connection between the two filers or any improper coordination. Members of Congress, their spouses, and company insiders operate under different disclosure regimes and different motivations, and STOCK Act filings exist precisely so the public can see these trades as they are reported, not to allege wrongdoing. Filing a Periodic Transaction Report is a legal obligation for members of Congress and their immediate family, not evidence of any violation.
Solstice Advanced Materials Inc. trades under the SOLS ticker, and this filing lists the asset simply as common stock. No additional detail on the rationale for the sale, the exact number of shares involved, or the identity of the financial institution behind Trust 2 was included in the disclosure.
Readers interested in the broader pattern can watch for additional filings tied to SOLS in the coming weeks, both from members of Congress and from corporate insiders, as more transactions in this window are reported to regulators.